Vernalis

Infobox_Company
company_name = Vernalis "plc"
(LSE:VER.L Nasdaq:VNLS)
company_
company_type = Public
foundation = 2003 "from merger"
location = Winnersh, United Kingdom
industry = Biotechnology
key_people = CEO
Robert Mansfield, 1992-2003
Simon Sturge, 2003-
Chair
George Kennedy, 2000-2003
Peter Fellner, 2003-
products = Frovatriptan, Apokyn
num_employees = 200
homepage = [http://www.vernalis.com/ver/ Vernalis]

Vernalis Plc is a British based biotech company founded in 2003 by the merger of Vernalis Group with British Biotech in a deal valued at £90 million.cite web
year = 2003
url = http://www.advancesinlifescience.com/news_145.htm
title = Vernalis agrees £91m merger plan with British Biotech
work = Advances in Life Science
publisher = ALS
accessdate = 2003-07-03] The merger allowed British Biotech to ditch its historic but tarnished name.cite web
year = 1998
url = http://www.publications.parliament.uk/pa/cm199798/cmselect/cmsctech/888/88804.htm
title = Fifth Report
work = Select Committee on Science and Technology
publisher = House of Commons
accessdate = 2007-11-28] The company has marketed two drug products; Frovatriptan,, [cite web |title=Patient Information Sheet -- Frovatriptan succinate (marketed as Frova) |url=http://www.fda.gov/cder/drug/InfoSheets/patient/frovatripanPIS.htm |date=07/2006 |publisher=Food and Drug Administration |accessdate=2007-11-28] to treat migraine, and Apokyn, an apomorphine-based drug for advanced Parkinson's disease.cite web
year = 2004
url = http://www.fda.gov/Cder/consumerinfo/druginfo/Apokyn.HTM
title = Apokyn
work =
publisher = FDA
accessdate = 2004-07-29]

The company has a development pipeline focused on CNS disease and oncology, and collaborates with pharmaceutical companies including Novartis, Servier, ChemGenex and Serono.

External links

* [http://www.vernalis.com/ver/ Company's home page]

References